Clinical Trials Directory

Trials / Completed

CompletedNCT02903615

Optimising Health in Type 1 Diabetes

The Optimal Diet for Optimising Health in Type 1 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Garvan Institute of Medical Research · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Type 1 diabetes is an autoimmune condition where circulating immune cells destroy the beta-cells in the pancreas that make insulin, resulting in a degree of insulin deficiency, whereby blood glucose levels rise and diabetes develops. When there is severe insulin deficiency, life-threatening ketoacidosis can develop. Treatment is lifelong insulin replacement therapy; dietary intervention is a also cornerstone of glucose management. The Optimise Diet is a multi-pronged diet based on "best health" principles: to minimise blood glucose rises after eating, reduce the immune cells involved in destruction of the insulin-secreting beta-cells, and improve the gut microbiome and systemic inflammation. In this study, its effects will be compared to the Standard Diabetes Diet that is currently recommended in Australia and internationally.

Detailed description

The rationale for this study is to determine whether a diet based on recent scientific advances in diet-induced inflammation, will improve diabetes care in people with type 1 diabetes.

Conditions

Interventions

TypeNameDescription
OTHERNovel dietNovel diet to optimise glucose levels and minimise systemic inflammation: altered macronutrient composition: lower carbohydrate, Mediterranean-style, prebiotic fibre focus.
OTHERStandard dietStandard diabetes diet recommendations

Timeline

Start date
2016-09-01
Primary completion
2020-06-30
Completion
2020-06-30
First posted
2016-09-16
Last updated
2022-03-22

Locations

2 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT02903615. Inclusion in this directory is not an endorsement.